08:56 AM EST - Oncolytics Biotech Inc : Today announced a strategic update highlighting its compelling clinical data from two tumor types and outlining a sharpened focus on advancing pelareorep, the Company's intravenously delivered oncolytic virus immunotherapy, into registration-enabling studies. Oncolytics Biotech Inc
shares N.ONCY are trading up $0.09 at $1.01.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=8832643753638470
